# Qilu SYNVA Pharmaceutical Co. Ltd, Dezhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/qilu-synva-pharmaceutical-co-ltd/fda44d3b-5f42-4cde-9760-cf4147fc0ef8

> Inspection records and compliance data for Qilu SYNVA Pharmaceutical Co. Ltd in Dezhou. 4 FDA inspections on record, 2 Form 483s, last inspected May 16, 2025.

---

## Details

- Name: Qilu SYNVA Pharmaceutical Co. Ltd
- FEI Number: 3006385404
- Address Line 1: 28 Licheng Ave, Linyi County
- City: Dezhou
- Country Name: China
- Address: 28 Licheng Ave, Linyi County, Dezhou, China
- Country: China

## Related Documents

- [483 - Qilu SYNVA Pharmaceutical Co. Ltd - 2025-05-16](https://www.keypedia.com/records/483/qilu-synva-pharmaceutical-co-ltd/d5429ebd-a562-4752-85f4-d714c898528d) — source: FDA, date: May 16, 2025
- [FDA Inspection 1275186 - Qilu SYNVA Pharmaceutical Co. Ltd - 2025-05-16](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/30ffc884-2b4e-4c89-a9dc-aed7726693e9) — source: FDA, date: May 16, 2025
- FDA Inspection 1275186 - Qilu SYNVA Pharmaceutical Co. Ltd - 2025-05-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 16, 2025
- [FDA Inspection 1115250 - Qilu SYNVA Pharmaceutical Co. Ltd - 2019-12-13](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/98f9dfc4-68b0-4ac7-b1d5-463d73859013) — classification: No Action Indicated (NAI), source: FDA, date: December 13, 2019
- [FDA Inspection 1098879 - Qilu SYNVA Pharmaceutical Co. Ltd - 2019-07-26](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/a2d93be4-63c0-40b0-a088-b95799038fdb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2019
- [FDA Inspection 980987 - Qilu SYNVA Pharmaceutical Co. Ltd - 2016-06-17](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/a52407b2-ed98-4b6b-b089-41bafd040439) — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2016

## Related Companies

- [BioSpectra, Inc.](https://www.keypedia.com/companies/biospectra-inc/ffb13a38-4f04-49cb-a6fe-fd55f544fcf0)
- [Siegfried (Nantong) Pharmaceuticals Co., Ltd.](https://www.keypedia.com/companies/siegfried-nantong-pharmaceuticals-co-ltd/0f735555-bd37-452f-b5f5-a205454957c1)
- [Norchim](https://www.keypedia.com/companies/norchim/b562ff1d-91f8-477f-b23e-7d4bcb5aa618)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/3a9656ad-737b-4682-9ab3-951b1041002e)
- [Zhejiang Jiuzhou Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-jiuzhou-pharmaceutical-co-ltd/6ff21ff3-4c18-4e07-9c38-79e499bfb8fa)
- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [PolyPeptide Laboratories, Inc.](https://www.keypedia.com/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Sparhawk Laboratories Inc](https://www.keypedia.com/companies/sparhawk-laboratories-inc/0edcf26d-ffdf-460f-b9fd-264b336000d5)
- [Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd](https://www.keypedia.com/companies/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/0a04fd37-1d04-4aa6-96f6-a25e6b2c756b)
- [Livzon Group (Ningxia) Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-group-ningxia-pharmaceutical-co-ltd/78a1f9d4-41d0-440a-87bc-8c9521d0159a)

## Related Officers

- [Investigator](https://www.keypedia.com/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36)